University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patients

Simple item page
dc.contributor.authorOkoliegbe, Ijeoma
dc.contributor.authorHijazi, Karolin
dc.contributor.authorCooper, Kim
dc.contributor.authorIronside, Corinne
dc.contributor.authorGould, Ian M
dc.contributor.institutionUniversity of Aberdeen.Dental Educationen
dc.date.accessioned2021-04-19T23:18:13Z
dc.date.available2021-04-19T23:18:13Z
dc.date.embargoedUntil2021-04-20
dc.date.issued2020-10
dc.descriptionAcknowledgements: The authors would like to thank the laboratories and clinicians who use the Cystic Fibrosis Antibiotics Susceptibility testing service (CFASS) for their support in sending samples. CFASS is an adult patient testing facility funded by the National Services Division of the Common Services Agency of the Scottish Executive. Achromobacter spp. identification was supported by grants from the University of Aberdeen and the NHS Grampian Clinical Microbiology Fund (NHS Grampian Endowment Funds Registered Charity Number SC017296). IMG serves as a consultant to and/ speaker to Pfizer and MSD. All other authors declare no competing interesten
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent550432
dc.identifier173616543
dc.identifierf10df0c5-d9ed-4b14-893d-d52f73d82d13
dc.identifier32816722
dc.identifier85094219484
dc.identifier000580642600035
dc.identifier.citationOkoliegbe, I, Hijazi, K, Cooper, K, Ironside, C & Gould, I M 2020, 'Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patients', Antimicrobial Agents and Chemotherapy, vol. 64, no. 11, e01467-20. https://doi.org/10.1128/AAC.01467-20en
dc.identifier.doi10.1128/AAC.01467-20
dc.identifier.iss11en
dc.identifier.issn0066-4804
dc.identifier.otherORCID: 0000-0002-7886-7064
dc.identifier.otherORCID: 0000-0002-8589-2129
dc.identifier.urihttps://hdl.handle.net/2164/16272
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85094219484&partnerID=8YFLogxKen
dc.identifier.vol64en
dc.language.isoeng
dc.relation.ispartofAntimicrobial Agents and Chemotherapyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAchromobacter sppen
dc.subjectA. xylosoxidansen
dc.subjectCystic Fibrosisen
dc.subjectAntimicrobial susceptibility testingen
dc.subjectSynergy testingen
dc.subjectEtesten
dc.subjectRK Dentistryen
dc.subjectR Medicineen
dc.subjectPharmacology (medical)en
dc.subjectInfectious Diseasesen
dc.subjectPharmacologyen
dc.subjectOtheren
dc.subjectSC017296en
dc.subject.lccRKen
dc.subject.lccRen
dc.titleLongitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patientsen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Okoliegbe_et_al_AAC_LongitudinalSurveillanceAnd_AAM.pdf
Size:
537.53 KB
Format:
Adobe Portable Document Format
Download

Collections

All research